|
Property
|
AS patients (n = 20)
|
Healthy controls (n = 20)
|
|---|
|
Male/ Female
|
15/5 (75%/25%)
|
15/5 (75%/25%)
|
|
Age
|
35 ± 11.3
|
36 ± 7.4
|
|
BASDAI
|
6.4 ± 2
|
–
|
|
BASFI
|
4.5 ± 2.6
|
–
|
|
BASMI
|
3.2 ± 1.2
|
–
|
|
Disease duration
|
8.7 ± 9.8
|
–
|
|
HLA-B27 positive
|
80%
|
0
|
|
ESR
|
29.3 ± 25.2
|
–
|
|
ASQol
|
9.6 ± 4.8
|
–
|
- AS ankylosing spondylitis, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, BASMI Bath Ankylosing Spondylitis Metrology Index, HLA-B27 Human Leukocyte Antigen (subtypes B*2701–2759), ESR Erythrocyte Sedimentation Rate, ASQol Ankylosing Spondylitis Quality of Life
